Pirfenidone

製品コードS2907 バッチS290706

印刷

化学情報

Synonyms

S-7701, AMR-69

Storage
(From the date of receipt)

3 years -20°C powder
1 years -80°C in solvent

化学式

C₁₂H₁₁NO

分子量

185.22

CAS No.

53179-13-8

Solubility (25°C)*

体外

DMSO

37 mg/mL (199.76 mM)

Ethanol

37 mg/mL (199.76 mM)

Water

10 mg/mL (53.98 mM)

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension

CMC-NA

≥5mg/ml

Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	Pirfenidone is an inhibitor for TGF-β production and TGF-β stimulated collagen production, reduces production of TNF-α and IL-1β, and also has anti-fibrotic and anti-inflammatory properties. Pirfenidone attenuates chemokine (CC motif) ligand-2 (CCL2) and CCL12 production with anti-fibrotic activity. Phase 3.
in vitro	Pirfenidone (< 300 μg/mL) suppresses the proinflammatory cytokine tumor necrosis factor-α (TNF-α) by a translational mechanism in RAW264.7 cells, which is independent of activation of the mitogen-activated protain kinase (MAPK) 2, p38 MAP kinase, and c-Jun N-terminal kinase (JNK). ^[1] This compound (< 10 mM) leads to reduced glioma cell density in concentration-dependent manner in LN-18, T98G, LNT-229 and LN-308 cell lines. It (< 5 mM) reduces TGF-β bioactivity by affecting TGF-β2 mRNA expression and processing of pro-TGF-β in CCL-64 cells. This chemical (< 8.3 mM) inhibits the activity of recombinant furin and downregulates the expression of MMP-11 in a dose-dependent manner in LN-308 cells. ^[2]
in vivo	Pirfenidone (250 mg/kg) potently inhibits the production of the proinflammatory cytokines, TNF-alpha, interferon-gamma, and interleukin-6, but enhances the production of the anti-inflammatory cytokine, interleukin-10, in mice. ^[1] This compound (250 mg/kg/day) ameliorates cyclosporine-induced fibrosis by about 50% and decreases TGF-beta1 protein expression by 80% in Sprague-Dawley rats receiving a low-salt diet. ^[3] It (400 mg/kg/day) inhibits heat shock protein 47-positive cells and myofibroblasts, the principal cells responsible for the accumulation and deposition of extracellular matrix seen in pulmonary fibrosis in ICR mice intravenously injected with bleomycin. ^[4] This chemical (0.5%, liquid diet) treatment reduces the degree of liver injury in rats, as determined by alanine aminotransferase values and necro-inflammatory score, which is associated with reduced hepatic stellate cells proliferation and collagen deposition. This compound (0.5%, liquid diet) administration downregulates dimethylnitrosamine induced transcripts levels of procollagen alpha1(I), TIMP-1 and MMP-2 by 50-60% in rats, and this is associated with a 70% reduction in collagen deposition. ^[5]

製品説明

Pirfenidone is an inhibitor for TGF-β production and TGF-β stimulated collagen production, reduces production of TNF-α and IL-1β, and also has anti-fibrotic and anti-inflammatory properties. Pirfenidone attenuates chemokine (CC motif) ligand-2 (CCL2) and CCL12 production with anti-fibrotic activity. Phase 3.

in vitro

Pirfenidone (< 300 μg/mL) suppresses the proinflammatory cytokine tumor necrosis factor-α (TNF-α) by a translational mechanism in RAW264.7 cells, which is independent of activation of the mitogen-activated protain kinase (MAPK) 2, p38 MAP kinase, and c-Jun N-terminal kinase (JNK). ^[1]

This compound (< 10 mM) leads to reduced glioma cell density in concentration-dependent manner in LN-18, T98G, LNT-229 and LN-308 cell lines. It (< 5 mM) reduces TGF-β bioactivity by affecting TGF-β2 mRNA expression and processing of pro-TGF-β in CCL-64 cells. This chemical (< 8.3 mM) inhibits the activity of recombinant furin and downregulates the expression of MMP-11 in a dose-dependent manner in LN-308 cells. ^[2]

in vivo

Pirfenidone (250 mg/kg) potently inhibits the production of the proinflammatory cytokines, TNF-alpha, interferon-gamma, and interleukin-6, but enhances the production of the anti-inflammatory cytokine, interleukin-10, in mice. ^[1]

This compound (250 mg/kg/day) ameliorates cyclosporine-induced fibrosis by about 50% and decreases TGF-beta1 protein expression by 80% in Sprague-Dawley rats receiving a low-salt diet. ^[3]

It (400 mg/kg/day) inhibits heat shock protein 47-positive cells and myofibroblasts, the principal cells responsible for the accumulation and deposition of extracellular matrix seen in pulmonary fibrosis in ICR mice intravenously injected with bleomycin. ^[4]

This chemical (0.5%, liquid diet) treatment reduces the degree of liver injury in rats, as determined by alanine aminotransferase values and necro-inflammatory score, which is associated with reduced hepatic stellate cells proliferation and collagen deposition. This compound (0.5%, liquid diet) administration downregulates dimethylnitrosamine induced transcripts levels of procollagen alpha1(I), TIMP-1 and MMP-2 by 50-60% in rats, and this is associated with a 70% reduction in collagen deposition. ^[5]

プロトコル(参考用のみ)

細胞アッセイ	細胞株	ACHN cells
	濃度	0.5 mg/ml
	反応時間	12 h
	実験の流れ	Cells were treated with various concentrations of this compound.
動物実験	動物モデル	Sprague-Dawley rats receiving a low-salt diet
	投薬量	250 mg/kg
	投与方法	oral diet

参考

https://pubmed.ncbi.nlm.nih.gov/12098600/
https://pubmed.ncbi.nlm.nih.gov/17234158/
https://pubmed.ncbi.nlm.nih.gov/12099512/

https://pubmed.ncbi.nlm.nih.gov/15293605/
https://pubmed.ncbi.nlm.nih.gov/15571005/
https://pubmed.ncbi.nlm.nih.gov/35130111/

+ 展开

カスタマーフィードバック

: Data from [Data independently produced by Histochem Cell Biol, 2014, 142(4), 361-71]

: , , Am J Respir Cell Mol Biol, 2017, 57(1):77-90

: Data from [Data independently produced by , , Aging Cell, 2018, doi: 10.1111/acel.12788]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

A high-throughput analysis of novel anti-fibrotics in human adult cardiac fibroblasts [ Biomed Pharmacother, 2025, 188:118216]	PubMed: 40466395
Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis [ Eur Respir J, 2024, 2300580]	PubMed: 38359963
Huaier-induced suppression of cancer-associated fibroblasts confers immunotherapeutic sensitivity in triple-negative breast cancer [ Phytomedicine, 2024, 135:156051]	PubMed: 39299097
Aerosol inhalation of total ginsenosides repairs acute lung injury and inhibits pulmonary fibrosis through SMAD2 signaling-mediated mechanism [ Phytomedicine, 2024, 133:155871]	PubMed: 39098168
Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in Retinal Wound Repair [ Cells, 2024, 13(2)164]	PubMed: 38247855
Pirfenidone Prevents Heart Fibrosis during Chronic Chagas Disease Cardiomyopathy [ Int J Mol Sci, 2024, 25(13)7302]	PubMed: 39000409
Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice [ Front Oncol, 2024, 14:1351839]	PubMed: 38590657
Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing [ Eur J Med Res, 2024, 29(1):231]	PubMed: 38609993
Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse [ bioRxiv, 2024, 2024.06.21.600035]	PubMed: 38979191
Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis [ Acta Pharmacol Sin, 2023, 10.1038/s41401-023-01156-w]	PubMed: 37696989

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。